Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Aging Neurosci.

Sec. Parkinson’s Disease and Aging-related Movement Disorders

Volume 17 - 2025 | doi: 10.3389/fnagi.2025.1693417

This article is part of the Research TopicAdvances in Early Detection, Pathophysiology, and Management of Mild Cognitive ImpairmentView all articles

Prevalence, associated factors and impact of mild cognitive impairment in hospitalized older adults with Parkinson's disease: A cross-sectional study

Provisionally accepted
Siyuan  GongSiyuan GongTianqi  WangTianqi WangRongzhu  TangRongzhu TangWangjuan  HuWangjuan HuWenjing  WangWenjing WangJia  LiJia LiJihong  LiuJihong Liu*Chunlian  LiaoChunlian Liao*
  • Neurology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China

The final, formatted version of the article will be published soon.

Background: Early identification of mild cognitive impairment (MCI) and timely interventions are essential to delay dementia in Parkinson's disease (PD). This study aims to examine the prevalence of MCI among hospitalized older adults with PD, preliminarily identify related factors, and explore its possible clinical impact, with the goal of providing evidence to inform more targeted screening and intervention strategies. Methods: A cross-sectional survey was conducted in China. From July 2022 to January 2025, a total of 339 hospitalized older adults with PD were recruited from a hospital using convenience sampling. Data were collected on demographic characteristics, biochemical markers, and clinical assessments. MCI was evaluated using the Mini-Mental State Examination. Univariate analysis was conducted to examine potential associations between MCI and the collected variables. Multivariate logistic regression was then used to identify independent factors and their impact associated with MCI in hospitalized older adults with PD. Results: The results showed that the prevalence of MCI in hospitalized older adults with PD was 45.4%. Multivariate logistic regression analysis revealed that MCI in hospitalized older adults with PD was significantly associated with education level of primary and below [OR = 6.358, 95% CI (2.542, 15.902)] and junior [OR = 4.782, 95% CI (1.965, 11.635)], higher MDS-UPDRS-III scores [OR = 1.023, 95% CI (1.007, 1.039)], presence of anxiety [OR = 2.045, 95% CI (1.080, 3.873)], lower hemoglobin levels [OR = 0.983, 95% CI (0.968, 0.998)], and longer hospitalization duration [OR = 1.833, 95% CI (1.113, 3.017)]. Conclusions: Our study observed a relatively high prevalence of MCI among hospitalized older adults with PD, and identified several associated factors, including lower educational level, greater severity of motor symptoms, anxiety, and reduced hemoglobin levels. These findings provide preliminary insights into factors that may warrant consideration when designing PD-MCI screening and intervention programs. Notably, we also found an association between PD-MCI and longer hospitalization duration, suggesting that early identification and management of MCI may help improve patient outcomes and reduce hospitalization burden.

Keywords: Parkinson's disease, Mild Cognitive Impairment, Prevalence, Associated factors, impact

Received: 27 Aug 2025; Accepted: 17 Oct 2025.

Copyright: © 2025 Gong, Wang, Tang, Hu, Wang, Li, Liu and Liao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Jihong Liu, ljhcq@cqmu.edu.cn
Chunlian Liao, 300259@hospital.cqmu.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.